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Background: During surgery, ischaemic pre- (IPC) and post-conditioning (IPO) protects the liver against
ischaemia/reperfusion injuries (I/R-injuries). The impact of ischaemic conditioning on liver regeneration
has been less well studied. Angiogenesis is an important part of liver regeneration after hepatectomy. The
aim of the present study was to investigate the effect of ischaemia/reperfusion and ischaemic condition-
ing on the expression of genes with angiogenic potential in a model of rat liver ischaemia.
Methods: A model of total liver ischaemia (30 min) and reperfusion (30 min) was employed using Wistar
rats. Rats were randomized into five groups: (C) control (IRI) ischaemic, IPC, IPO and IPC + IPO. Liver
enzymes were sampled at the end of reperfusion. Liver biopsies were analysed using cDNA microarrays.
Results: Alanine aminotransferase (ALT) increased significantly in all the ischaemic groups compared
with controls (P = 0.000). Searching databases 99 genes involved in rat liver angiogenesis were identified.
Compared with group (C) the number of genes significantly up-regulated was as follows: IRI (n = 5), IPC
(n = 24), IPO (n = 33) and IPC + IPO (n = 18). No genes were down-regulated in the four groups compared
with controls.
Conclusion: Ischaemic conditioning, as demonstrated in the present study, seems to be potent
activators of angiogenic genes. This might be favourable to the regenerating liver.
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Introduction
During hepatic resection of malignancies it is of great importance
to perform the procedure safely, without transfusion demanding
blood loss. Blood transfusion in this setting is known to have a
negative impact on both peri- and post-operative morbidity and
mortality, and on the long-term oncological outcome.1–3 Vascular
clamping is a frequently used method to control blood loss.4
However, this causes varying degrees of ischaemia/reperfusion
injuries (I/R-injuries) in the liver tissue, depending on the length
of the ischaemic period, the presence of an underlying hepatic
disease and the usage of hepato-protective methods such as
ischaemic condition.
It has been demonstrated, that ischaemic pre- and post-
conditioning (IPC or IPO), defined as brief periods of ischaemia
and reperfusion before or after sustained ischaemia, reduces the
extent of I/R-injuries in the liver.5–7 This hepatoprotection against
I/R-injuries seems to be mediated by a widespread activation of
basic cellular mechanisms, resulting in an increased resistance to
oxidative stress and inflammation.8
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Angiogenesis is an important part of liver regeneration after
hepatectomy.9 The effect of I/R and ischaemic conditioning on
the expression of genes with angiogenic potential is virtually
unknown. The aim of the present study was to profile and
compare expression levels of genes, involved in rat liver angiogen-
esis, subjected to different ischaemic protocols.
Methods
Experimental design
The surgical and experimental protocols were approved by the
Danish Research Animal Committee, Copenhagen, Denmark,
according to license number 2007/561–1311 and followed the
Guide for the Care and Use of Laboratory Animals, published by the
National Board of Health.
Forty-eight male Wistar rats, weighing 300–350 g (M & B
Taconic, Eiby, Denmark), were used for the experiment. Animals
were housed in standard animal laboratories with a constant tem-
perature of 23°C and artificial 12-h light/dark cycles. They had
free access to food and water until the start of the experiment.
The rats were divided into five groups: (C) control (n = 8) (IRI)
ischaemia (n = 10) (IPC) (n = 10) (IPO) (n = 10) and (IPC + IPO)
(n = 10). All animals were anaesthetized using 0.75 mL/kg
Hypnorm subcutaneously (s.c.) (fentanyl/fluanisone; Jansen
Pharma, Birkeroed, Denmark) and 4 mg/kg Midazolam s.c. (dor-
micum; La Roche, Basel, Switzerland), and then placed on a
heating pad. A midline laparotomy was performed, and total
hepatic ischaemia was accomplished using a microvascular clip,
placed on the hepatoduodenal ligament, i.e. the Pringle manoeu-
vre. Reflow was initiated after 30 min of ischaemia by removal of
the clamp. Discoloration of the liver was used as a positive marker
for hepatic ischaemia. Reperfusion was ascertained by the return
of the normal reddish colour of the liver.
Rats in the control group were operated on in the same way as
the other groups using mobilization of the hepatoduodenale liga-
ment, but without placing a microvascular clip. All other rats were
subjected to 30 min of total hepatic ischaemia, followed by 30 min
of reperfusion before a biopsy was taken from the liver. In the IPC
groups, animals were subjected to 10 min of hepatic ischaemia,
followed by 10 min of reperfusion prior to the sustained 30 min of
ischaemia. In the IPO group, three cycles, each composed of 30 s
of reperfusion and 30 s of ischaemia, were applied immediately
after onset of reperfusion. The IPC + IPO groups were subjected
to a combination of the two interventions before and after
ischaemia (Fig. 1).
At the end of each experiment a biopsy was taken from the right
liver lobe. The biopsy was immediately frozen in liquid nitrogen
and stored at -80°C for further analysis. From the common iliac
artery blood samples were taken for measurement of alanine
aminotransferase (ALT), alkaline phosphates and bilirubin.
Afterwards all rats were killed with an overdose of pentobarbital.
RNA isolation
Liver samples were thawed and the tissue was homogenized
in RLT plus buffer on the Tissuelyser (Qiagen, Hilden, Germany)
and total RNA extracted on the QIAsymphony SP (Qiagen) using
the QIAsymphony RNA extraction kit.
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Figure 1 Experimental protocol for the five groups. Black areas represent periods of hepatic ischaemia, white areas represent periods of
normal hepatic blood perfusion. Liver biopsies were collected at the end of each experiment. IRI, 30 min of ischaemia. IPC, ischaemic
pre-conditioning + 30 min of ischaemia. IPO, 30 min ischaemia + ischaemic post-conditioning. IPC + IPO, ischaemic pre-conditioning +
30 min of ischaemia + ischaemic post-conditioning
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Microarray analysis
For Gene expression analysis, the following procedures were
performed all according to Affymetrix (Santa Clare, CA, USA)
standard procedures. Briefly, 150 ng total RNA was used for the
target preparation as a starting material with the cDNA Syntesis
Kit and WT Terminal Labeling Kit. The target was loaded onto the
Affymetrix Rat Exon 1.0 ST array cartridge and hybridized for
16 h. The arrays were washed and stained in the Affymetrix
Fluidics Station and scanned using the Affymetrix 7G GeneChip
Scanner.
The raw image files from the quantitative scanning were
analysed by Affymetrix Gene Expression Analysis Software and
data were normalized using the RMA in Affymetrix Expression
Console.
Gene expression analysis
Gene expression levels were analysed in the five groups using
Affymetrix Rat Exon 1.0 ST array. This standard array, compris-
ing 29.215 probe sets, detects the expression levels of all rat genes.
From the probe set we selected all genes known to be involved in
angiogenesis in the rat, and compared expression levels of genes
between our experimental groups. This selection was based on a
search for genes involved in rat angiogenesis in the Ingenuity
Pathway database and the data sheet supplied with the microar-
ray. We hereby identified 99 genes, which were the basis of the
following data analysis. The 99 genes were divided into three
main function areas: inducers, inhibitors and modulators of
angiogenesis.
Statistical analyses
Statistical analyses of blood samples were performed by SPSS®
11.0 (SPSS Inc., Chicago, IL, USA). Data analyses were performed
by the non-parametric Kruskal–Wallis (anova) test, followed
by the Mann–Whitney U-test. A P-value < 0.05 was considered
significant.
Significance analysis of microarray data was performed in open
source TM4 software Multiexperiment Viewer v4.5,10 using signifi-
cance analysis for microarrays (SAM), which is a statistical tech-
nique especially developed for microarray data analysis. It assigns
a score to each gene on the basis of change in gene expression
relative to the standard deviation of repeated measurements. For
genes with scores greater than an adjustable threshold, SAM uses
permutations of the repeated measurements to estimate the per-
centage of genes identified by chance, as described by Tusher
et al.11
As cutoff levels of significance we used the smallest delta value
with a False Discovery Rate = 0.
Results
Blood samples
Blood samples showed a significant increase in ALT in the groups
IRI, IPC, IPO, and IPC + IPO compared with the control group
(P = 0.000). Further, ALT was significantly elevated in the IPC +
IPO group compared with the IRI (P = 0.043) and IPC (P = 0.015)
groups. No difference was found between the IPO and IPC + IPO
groups (Fig. 2). Alkaline phosphate and bilirubin were compa-
rable between the groups.
Supervized SAM two class unpaired
The effects of ischaemia and reperfusion and ischaemic condi-
tioning on gene expression levels were compared in a two class
unpaired SAM analysis. Here we tested the four intervention
groups against the control group. Results are described in Fig. 3.
IRI only affects 5 out of 99 genes significantly. A major increase
in genes affected was observed in the conditioned groups,
with 24 (IPC), 33 (IPO) and 18 (IPC + IPO) genes significantly
up-regulated. None of the tested genes were down-regulated after
ischaemia or ischaemic conditioning when compared with expres-
sion levels in the control group. All affected genes are listed in
Table 1.
Supervised SAM multiclass
A multiclass analysis of all five groups revealed 20 genes with
significant changes across the five groups. These genes are listed in
Table 2. Figure 4 is a hierarchical cluster of rat liver samples based
on these 20 significant genes. This cluster dendrogram separates
the conditioned groups from the IRI and control group.
Discussion
In the present study we tested how I/R and ischaemic conditioning
affected the expression levels of genes known to be involved in
* #
IRI IPC IPO IPC + IPO Control
A
LT
 (
U
/L
)
0
500
1000
1500
2000
2500
Figure 2 Scatter plot of alanine aminotransferase (ALT) levels in
rat serum after 30 min of reperfusion in the five groups. Horizontal
lines represents mean of groups. IRI, 30 min of ischaemia (n = 10).
IPC, ischaemic pre-conditioning + 30 min of ischaemia (n = 10).
IPO, 30 min ischaemia + ischaemic post-conditioning (n = 10). IPC +
IPO, ischaemic pre-conditioning + 30 min of ischaemia + ischaemic
post-conditioning (n = 10), control (n = 8). *Group IRI compared
with IPC + IPO, P = 0.043; †group IPC compared with IPC + IPO,
P = 0.015. H17009control group compared with the four intervention
groups, P = 0.000
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angiogenesis in the rat liver. We demonstrated that IRI, IPC, IPO
and IPC + IPO significantly affected the expression of many
angiogenic genes. This has not previously been reported. A com-
parison analysis with intervention groups and controls showed
a pronounced increase in the number of genes involved in an-
giogenesis in groups subjected to ischaemic conditioning. The
number of inhibitors was fairly constant in the different groups,
but inducers, and especially modulators, of angiogenesis was
affected by ischaemic conditioning. Another interesting observa-
tion was that none of the tested genes were down-regulated. A
multiclass analysis identified 20 genes with significantly affected
expression levels. A subsequent cluster analysis divided these
genes (Fig. 4) into two clusters: one containing the control and IRI
groups and one containing the conditioned groups. This led us to
conclude that IPC, IPO and IPC + IPO affect genes involved in
angiogenesis differently than does IRI.
The 99 genes involved in angiogenesis have very different effects
on this complicated process, which involves degradation of the
basement membrane of the capillaries, migration of endothelia
cells and organization into new capillary tubes.12 Angiogenesis
is controlled locally by changes in the equilibrium of inducers,
inhibitors and modulators. We divided genes into one of these
three groups, knowing that some of the genes might fit into more
than one group. Vascular endothelia growth factor (VEGF) is one
Figure 3 Pair-wise comparison of groups vs. control by unsuper-
vised significance analysis for microarrays (SAM) two class
unpaired. Describes the number of genes with significantly
up-regulated expression levels in the rat liver. Black areas represent
angiogenesis inducing agents, pale grey angiogenesis inhibitors and
dark grey angiogenesis modulating agents. All of the 99 genes
tested in this comparison analysis are known to be involved in
angiogenesis. IRI, 30 min of ischaemia. IPC, ischaemic precondi-
tioning + 30 min of ischaemia. IPO, 30 min ischaemia + ischaemic
post-conditioning. IPC + IPO, ischaemic pre-conditioning + 30 min
of ischaemia + ischaemic post-conditioning
Table 1 Pair-wise comparison of groups vs. control by significance
analysis for microarrays (SAM) two class unpaired
Gene symbol IRI IPC IPO IPC + IPO
Angiogenesis inhibitors
Il1rn + + +
Rnh1 +
Scye1 + + +
Serpinf1 + + +
Wars +
Angiogenesis modulating agents
Anpep + + +
C1galt1 +
Ccnd1 + + + +
Ceacam1 +
Cyr61 + + +
Elk3_predicted + +
Enpep + +
Mmp14 + +
Pik3r1 + +
Plau + +
Ppap2b +
Pten +
Ptprj +
Rela + + +
Serpine1 + + +
Smad5 + +
Sphk2 + + +
Tnfrsf12a + +
Tnfrsf1a + + +
Zfp36l1 + + +
Angiogenesis inducers
Ang2 + +
Angptl2 +
Arts1 +
Ccl2 + + + +
Epas1 + +
Flt1 +
Lgals3 + + +
Myc + + + +
Nrg1 + +
Pold4 +
Tgfb1 +
Vegfa +
Yars + +
+ indicates a significant up regulation of expression level in the rat liver
compared with the control group. The table categorise genes into three
main functions on angiogenesis. All of the 99 genes tested in this com-
parison analysis are known to be involved in rat angiogenesis. IRI, 30 min
of ischaemia. IPC, ischaemic pre-conditioning + 30 min of ischaemia. IPO,
30 min ischaemia + ischaemic post-conditioning. IPC + IPO, ischaemic
pre-conditioning + 30 min of ischaemia + ischaemic post-conditioning.
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of the most potent and well-characterized inducers of angiogen-
esis. VEGF expression levels seem to be directly correlated with the
angiogenic activity.13 VEGFa expression was increased in all con-
ditioned groups, but only significantly in the IPO group. Another
group of inducers are angiopoietins (ANG2, ANGPTL2 and
others), which are growth factors with largely specific effect on the
vascular endothelium.14 ANG2 expression was increased in the
IPO and IPC+IPO group, whereas ANGPTL2 expression was
up-regulated in the IPC group. Transforming growths factor beta
1 (TGF-b1) stimulates the extracellular matrix production in the
angiogenic process,12 but it also plays an important role in the
process of liver regeneration.15 TGF-b1 was up-regulated signifi-
cantly in the IPC group. Several genes are classified as modulators
as they are known to affect angiogenesis, without a clear inducing
or inhibitory effect. The matrix metallopeptidases (MMPs) are
some of the best characterized. They are involved in the remod-
elling of extracellular matrix during angiogenesis.12 In the IPC and
IPO group the expression of MMP14 gene was up-regulated. Only
a few inhibitors of angiogenesis were affected, one of these was
IL1RN, which is an interleukin-(IL)1a and 1b antagonist. IL-1a
and 1b are stimulators of VEGF production. IL1RN was signifi-
cantly up-regulated in groups IPC, IPO and IPC+IPO. All genes
affected can be seen in Table 1.
Circulating ALT levels increased in the four groups subjected to
sustained ischaemia compared with the control group. This indi-
cates that our model did induce hepatocellular damage, as ALT is
a reliable marker for hepatocellular injuries.16 In the present study
IPC did not, as shown by other authors,5,6 affect ALT levels sig-
nificantly. This could be explained by the short reperfusion period
as hepatocellular damage develops during the first hours of rep-
erfusion. Most other studies using ALT as marker for cellular
damage have used longer reperfusion periods.6 We chose 30 min
Table 2 Significance analysis for microarrays (SAM) multi class
analysis of the five experimental groups
Gene symbol IRI IPC IPO IPC + IPO
Angiogenesis inhibitors
Il1rn 1.09 1.69 1.36 1.71
Scye1 1.02 1.54 2.10 1.68
Serpinf1 1.00 1.27 1.31 1.24
Angiogenesis modulating agents
Anpep 0.83 1.43 1.75 1.59
Bgn 0.73 1.12 1.23 1.18
Ccnd1 1.53 1.74 1.51 1.46
Ceacam1 0.56 0.96 1.31 1.12
Cyr61 1.43 2.38 2.61 2.17
Drd2 1.10 0.83 0.77 0.91
Enpep 0.84 1.31 1.47 1.34
Mmp14 0.90 1.37 1.41 1.17
Pten 0.88 1.18 1.46 1.33
Ptprj 0.72 1.03 1.29 1.22
Serpine1 1.27 1.79 1.32 1.49
Tnfrsf12a 1.14 1.46 1.22 1.15
Tnfrsf1a 1.23 1.61 1.69 1.69
Zfp36l1 1.02 2.08 2.02 2.02
Angiogenesis inducers
Myc 1.56 3.13 1.66 1.99
Sphk1 1.01 0.91 0.79 0.86
Yars 1.02 1.27 1.38 1.20
The table categorizes genes into three main functions on angiogenesis.
Numbers describes fold change in gene expression levels compared
with the control group. All of the 99 genes tested in this comparison
analysis are known to be involved in angiogenesis. IRI, 30 min of
ischaemia. IPC, ischaemic pre-conditioning + 30 min of ischaemia. IPO,
30 min ischaemia + ischaemic post-conditioning. IPC + IPO, ischaemic
pre-conditioning + 30 min of ischaemia + ischaemic post-conditioning.
Figure 4 Significance analysis for microarrays (SAM) multiclass
analysis identified 20 genes with different expression levels across
groups. A hierarchical cluster analysis of these genes is depicted in
this figure. Red areas indicate genes with high expression levels and
green areas genes with low expression levels. Expression levels are
calculated as amean of groups. The dendrogram on top of the figures
describes the association between groups with regard to similarity
of expression patterns. IRI, 30 min of ischaemia. IPC, ischaemic
pre-conditioning + 30 min of ischaemia. IPO, 30 min ischaemia +
ischaemic post-conditioning. IPC + IPO, ischaemic pre-conditioning
+ 30 min of ischaemia + ischaemic post-conditioning
558 HPB
HPB 2010, 12, 554–560 © 2010 International Hepato-Pancreato-Biliary Association
of reperfusion, as the early moments of reperfusion seem to be
essential in the pathogenesis of I/R-injuries.17 Another explana-
tion why we could not demonstrate a protective effect of condi-
tioning on ALT levels might be that 30 min of ischaemia resulted
in only minor I/R-injuries. Surprisingly, we found higher ALT
levels in animals subjected to IPO and IPC+IPO which indicate a
higher degree of hepatocellular damage. ALT, however, showed
large variations in groups subjected to IPO (see Fig. 2), but the
reasons for this are unclear. Despite this, in our model of I/R-
injuries, we found a pronounced impact of ischaemic condition-
ing on genes involved in angiogenesis and many of the genes
activated after the different conditioning protocols were identical.
Microarray analysis enables us to simultaneously investigate the
parallel expression levels of multiple genes, which is the major
strength of this method. A downside of this method is that when
we measure RNA copy numbers in the different groups, we cannot
be sure that this leads to an increase in protein concentrations,
these being the main effecter molecules. Our study focuses on the
general expression levels of all genes known to affect angiogenesis.
We identified angiogenic gene clusters within the experimental
groups. The expression levels of single genes were of minor inter-
est in this study and it would therefore be of little value to validate
single genes using other methods suh as, e.g. RT-PCR. In future
studies, when identifying key mediators of angiogenic activation
after ischaemic conditioning, a RT- PCR validation of findings are
of course mandatory.
Transfusion demanding blood loss during liver surgery is
known to have a negative impact on both peri- and post-operative
morbidity and mortality, and on the long-term oncological out-
come.2,3 Vascular clamping is a frequently used method to control
blood loss.4 However, this causes varying degrees of ischaemia/
reperfusion injuries ranging from a light elevation of liver
enzymes to liver failure. Many studies have demonstrated a pro-
tective effect of ischaemic pre- or post-conditioning5–7 on I/R-
injuries which seems to be mediated by a widespread activation of
basic cellular mechanisms.8 Despite efforts to reduce blood loss,
around 60–70% of patients treated with R0 liver resections for
colorectal metastases will experience a relapse of the disease
within 2 years, mainly in the liver.18,19 Intrahepatic recurrence
may originate from pre-existing micro-metastases in the liver
and these dormant micro-lesions are known to be present in
26–70% of liver specimens from patients with colorectal liver
metastases,20,21 and they are highly associated with a negative
oncological outcome. For tumour growth beyond 1–2 mm3
angiogenesis is required.12 The shift towards angiogenesis can be
triggered by an increased production of angiogenic factors, by the
liver or the tumour itself. I/R-injuries are known to stimulate the
outgrowth of micro-metastases in rodent models.22,23 In a recently
published study by Nijkamp et al. an association between pro-
longed portal triad clamping and decreased time to liver recur-
rence was ascertained.24 A strong angiogenic stimulus is suggested
to be one of the most likely explanations for this unfortunate
side effect of I/R-injuries.
In conclusion ischaemic conditioning, as demonstrated in the
present study, seems to be a potent activator of angiogenic genes.
In this sense conditioning may prove to be a double-edged sword,
i.e. it might be favourable to the regenerating liver, but may stimu-
late the growth of micrometastases.
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